一名患有COVID-19和失代偿期肝硬化的患者出现急性免疫性血小板减少性紫癜。
Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis.
作者信息
Artru Florent, Alberio Lorenzo, Moradpour Darius, Stalder Grégoire
机构信息
Service of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Service and Central Laboratory of Hematology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
出版信息
BMJ Case Rep. 2020 Jul 7;13(7):e236815. doi: 10.1136/bcr-2020-236815.
We report on a patient with coronavirus disease 2019 (COVID-19) and decompensated cirrhosis who experienced a favourable outcome of severe immune thrombocytopaenic purpura (ITP) after administration of intravenous immunoglobulin and high-dose dexamethasone. The present case suggests that it is reasonable to evoke ITP in case of profound thrombocytopaenia in a patient with COVID-19.
我们报告了一名患有2019冠状病毒病（COVID-19）和失代偿性肝硬化的患者，该患者在静脉注射免疫球蛋白和高剂量地塞米松后，严重免疫性血小板减少性紫癜（ITP）取得了良好疗效。本病例表明，对于COVID-19患者出现严重血小板减少的情况，考虑ITP是合理的。
Zotero 插件